Altering molecular mechanisms to prevent sudden arrhythmic death

This publication has 25 references indexed in Scilit:

• Effect of Beta-Blockade on Mortality in Patients With Heart Failure: A Meta-Analysis of Randomized Clinical Trials
  Journal of the American College of Cardiology, 1997
• Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT
  The Lancet, 1997
• Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT
  The Lancet, 1997
• Human Monocytes/Macrophages Release TNF-α in Response to Ox-LDL
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1996
• Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction
  The Lancet, 1996
• A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction
  New England Journal of Medicine, 1995
• Mildly Oxidized LDL Induces Platelet Aggregation Through Activation of Phospholipase A ₂
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• Effect of Left Ventricular Hypertrophy and Its Regression on Ventricular Electrophysiology and Vulnerability to Inducible Arrhythmia in the Feline Heart
  Circulation, 1995
• Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies.
  Circulation, 1991
• Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial Infarction
  New England Journal of Medicine, 1989